Shared on 31 Oct 25
Narrative Update: Neogen Analyst Price Target Revised Analysts have slightly raised their price target for Neogen, citing improvements in expected profit margins and a modest decline in projected future valuation multiples. This has resulted in a new estimated fair value of $8.17 per share.
Shared on 17 Oct 25
Fair value Increased 6.52%Food Safety Testing Advances Will Expand Global Opportunities
Neogen's analyst target price has risen from $7.67 to $8.17, as analysts point to improved revenue growth projections alongside a reduced discount rate, both supporting a higher valuation. What's in the News Neogen introduced Molecular Detection Assay: Listeria Right Now, a rapid, enrichment-free tool for detecting Listeria species with results in about two hours and streamlined workflow benefits (Product-Related Announcements).
Shared on 03 Oct 25
Fair value Increased 18%Food Safety Testing Advances Will Expand Global Opportunities
Analysts have raised their price target for Neogen from $6.50 to $7.67, citing a slightly lower discount rate and forward profit expectations. Revenue growth projections remain stable.
Shared on 01 Aug 25
Fair value Decreased 13%Food Safety Testing Advances Will Expand Global Opportunities
Despite improved revenue growth projections and a lower future P/E multiple, Neogen's consensus analyst price target has been cut from $7.50 to $6.50, highlighting a more cautious valuation outlook. What's in the News Neogen reported a goodwill impairment charge of $597.9 million for the three months ended May 31, 2025.